Cargando…

VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer

BACKGROUND: Breast cancer recurrence and metastasis are associated with alterations in the cellular stress responses that influence tumour signalling. Sirtuin3 (SIRT3), a mitochondrial deacetylase is the regulator of mitochondrial metabolism and oxidative stress affecting tumour cell responses. Gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Payavula, Harshitha Yadav, Jamadandu, Deepika, Velpula, Salomy, Digumarti, Raghunadha Rao, Satti, Vishnupriya, Annamaneni, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334083/
https://www.ncbi.nlm.nih.gov/pubmed/36974538
http://dx.doi.org/10.31557/APJCP.2023.24.3.859
_version_ 1785070791309656064
author Payavula, Harshitha Yadav
Jamadandu, Deepika
Velpula, Salomy
Digumarti, Raghunadha Rao
Satti, Vishnupriya
Annamaneni, Sandhya
author_facet Payavula, Harshitha Yadav
Jamadandu, Deepika
Velpula, Salomy
Digumarti, Raghunadha Rao
Satti, Vishnupriya
Annamaneni, Sandhya
author_sort Payavula, Harshitha Yadav
collection PubMed
description BACKGROUND: Breast cancer recurrence and metastasis are associated with alterations in the cellular stress responses that influence tumour signalling. Sirtuin3 (SIRT3), a mitochondrial deacetylase is the regulator of mitochondrial metabolism and oxidative stress affecting tumour cell responses. Genetic variants or dysregulation of SIRT3 was known to associate with poor prognosis of recurrence and relapse in few cancers. METHODS: The current case-control study was conducted in Hyderabad, India. A total of 200 primary female breast cancer cases were recruited, irrespective of age and clinical subtype. However, secondary or recurrent breast cancer cases were excluded from the study. A total of 202 age and gender-matched healthy controls without any familial inheritance of either breast or other cancer and having similar ethnicity as cases were recruited. The blood samples of both cases and controls were collected from Nizam’s Institute of Medical Sciences (NIMS), Hyderabad. Our study is an attempt to evaluate the association of SIRT3 VNTR polymorphism in intron 5 with the development and progression of breast cancer by PCR-based genotyping. RESULT: The statistical analysis of the results with respect to epidemiological and clinical phenotypes revealed significant association of 0R allele and 0R/0R genotype with breast cancer risk (p<0.01). The odds ratios also were found to be significant i.e., 0R/0R [OR(CI): 2.67(1.54-4.65); p=0.000005] genotype. Also, the epidemiological and clinical variables have shown significant association with the risk of onset of the disease. Therefore, the influence of lack of repeats at intron 5 harbouring enhancer site on altered expression of SIRT3 might confer increased susceptibility to breast cancer. CONCLUSION: The VNTR polymorphism in the intron 5 region of SIRT3 gene could serve as a molecular marker for detection of breast cancer onset. Further studies are warranted to study the prognostic and therapeutic significance of this SIRT3 polymorphism.
format Online
Article
Text
id pubmed-10334083
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-103340832023-07-12 VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer Payavula, Harshitha Yadav Jamadandu, Deepika Velpula, Salomy Digumarti, Raghunadha Rao Satti, Vishnupriya Annamaneni, Sandhya Asian Pac J Cancer Prev Research Article BACKGROUND: Breast cancer recurrence and metastasis are associated with alterations in the cellular stress responses that influence tumour signalling. Sirtuin3 (SIRT3), a mitochondrial deacetylase is the regulator of mitochondrial metabolism and oxidative stress affecting tumour cell responses. Genetic variants or dysregulation of SIRT3 was known to associate with poor prognosis of recurrence and relapse in few cancers. METHODS: The current case-control study was conducted in Hyderabad, India. A total of 200 primary female breast cancer cases were recruited, irrespective of age and clinical subtype. However, secondary or recurrent breast cancer cases were excluded from the study. A total of 202 age and gender-matched healthy controls without any familial inheritance of either breast or other cancer and having similar ethnicity as cases were recruited. The blood samples of both cases and controls were collected from Nizam’s Institute of Medical Sciences (NIMS), Hyderabad. Our study is an attempt to evaluate the association of SIRT3 VNTR polymorphism in intron 5 with the development and progression of breast cancer by PCR-based genotyping. RESULT: The statistical analysis of the results with respect to epidemiological and clinical phenotypes revealed significant association of 0R allele and 0R/0R genotype with breast cancer risk (p<0.01). The odds ratios also were found to be significant i.e., 0R/0R [OR(CI): 2.67(1.54-4.65); p=0.000005] genotype. Also, the epidemiological and clinical variables have shown significant association with the risk of onset of the disease. Therefore, the influence of lack of repeats at intron 5 harbouring enhancer site on altered expression of SIRT3 might confer increased susceptibility to breast cancer. CONCLUSION: The VNTR polymorphism in the intron 5 region of SIRT3 gene could serve as a molecular marker for detection of breast cancer onset. Further studies are warranted to study the prognostic and therapeutic significance of this SIRT3 polymorphism. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10334083/ /pubmed/36974538 http://dx.doi.org/10.31557/APJCP.2023.24.3.859 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Payavula, Harshitha Yadav
Jamadandu, Deepika
Velpula, Salomy
Digumarti, Raghunadha Rao
Satti, Vishnupriya
Annamaneni, Sandhya
VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title_full VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title_fullStr VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title_full_unstemmed VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title_short VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer
title_sort vntr polymorphism in the intron 5 of sirt3 and susceptibility to breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334083/
https://www.ncbi.nlm.nih.gov/pubmed/36974538
http://dx.doi.org/10.31557/APJCP.2023.24.3.859
work_keys_str_mv AT payavulaharshithayadav vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer
AT jamadandudeepika vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer
AT velpulasalomy vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer
AT digumartiraghunadharao vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer
AT sattivishnupriya vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer
AT annamanenisandhya vntrpolymorphismintheintron5ofsirt3andsusceptibilitytobreastcancer